BFEC
KRRO icon

Benjamin F. Edwards & Company’s Korro Bio KRRO Stock Holding History

Benjamin F. Edwards & Company’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17
Closed -$8K – 1727
2021
Q1 		$8K Hold
17
– – ﹤0.01% 1413
2020
Q4 		$31K Buy
+17
New +$22.4K ﹤0.01% 1071

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Benjamin F. Edwards & Company's KRRO Position: Q2 2021 in Review

Benjamin F. Edwards & Company sold out of Korro Bio (KRRO) in Q2 2021, closing a stake of 17 shares — an estimated $8K sold.

Benjamin F. Edwards & Company first reported a position in KRRO in Q4 2020 and held it in 2 quarters. The position peaked at $31K in Q4 2020. 91 funds tracked by Wall St. Rank hold KRRO as of Q2 2021.

  • Benjamin F. Edwards & Company reported no remaining Korro Bio position as of Q2 2021 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 17 Korro Bio shares in Q2 2021, an estimated $8K.
  • Benjamin F. Edwards & Company first reported a position in Korro Bio in Q4 2020 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's Korro Bio position peaked at $31K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Korro Bio as of Q2 2021.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2021, filed 11 Aug 2021.